Scivision Biotech Inc.

Two Decades in Hyaluronic Acid Industry
SciVision Biotech Inc., founded in 2001, is now a public company listed on Taiwan Stock Exchange (stock symbol: 1786). SciVision Biotech Inc. manufactures Hyaluronic acid products by using its own-developed Cross-linked Hyaluronic Acid Platform (CHAP) to make the characteristics of Hyaluronic acid products precisely controllable and can be widely used in the production of cross-linked Hyaluronic acid products with different types and physical properties. The technology of the Cross-linked Hyaluronic Acid Platform (CHAP) established the leading position of SciVision Biotech Inc. in the field of medical-grade Hyaluronic acid products.

Our Products
The population structures of both developed and developing countries are gradually moving towards an aging society. The pursuit of beauty and health, as well as the demand for medical care for degenerative diseases, has increased day by day. The main products of our company are Hyaluronic acid dermal fillers (for medical and cosmetic surgical use), Hyaluronic acid anti-adhesion gels (for surgical use) and Hyaluronic acid viscosupplement (for treatment of knee osteoarthritis). The three Hyaluronic acid products are high-level medical devices that cater to the commercial possibilities for the next 10-year growth. Today, our company has gradually increased the technology scale and is devoted to the health and beauty fields, to create a better vision and reach the human's aesthetic realm.

20,000sqm Factory
SciVision Biotech acquired a nearly 20,000 square meter site located in Kaohsiung Cianjhen Technology Industrial Park for the construction of a new manufacturing facility to accommodate the growing production needs. The facility was GMP certified and was constructed based on FDA standards, fully equipped with advanced automatic equipment.

Deal with Us Today
We work with pharmaceutical and specialty companies worldwide to develop long-term competitiveness. SciVision's vision is to contribute its accumulated technologies and experience for the benefit of all humankind, to develop high-quality and high-efficiency products, improve the health and the quality of life of the public, and to become a leading company in Taiwan's biotech industry while continuing our growth in the global market.